Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects (Q58030146)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects |
article |
Statements
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects (English)
S W Dubrey
D E Reece
U Hegenbart
J-P Fermand
R A Vescio
J Bladé
L T Heffner
H Hassoun
X Liu
C Enny
P Ramaswami
Y Elsayed
H Van De Velde
S Mortimer
A Cakana
R L Comenzo
Velcade Can2007 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference